Quick Answer
Zepp Health Corp reported Total Revenue of $182.60 million for fiscal year 2024.
Zepp Health Corp — Key Financials by Year
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Total Revenue | $182.60M -92.7% |
$2.50B -39.8% |
$4.14B -33.7% |
$6.25B -2.8% |
$6.43B +10.7% |
$5.81B +59.4% |
| Revenue (ASC 606) | $182.60M -48.3% |
$352.86M -42.5% |
$613.64M -90.2% |
$6.25B -2.8% |
$6.43B +10.7% |
$5.81B +59.4% |
| Net Income | -$75.73M -144.1% |
-$31.02M +28.3% |
-$43.24M -131.4% |
$137.80M -39.8% |
$228.75M -60.2% |
$575.20M +69.2% |
| Diluted EPS | -$0.29 -123.1% |
-$0.13 +27.8% |
-$0.18 -134.6% |
$0.52 -40.9% |
$0.88 -60.7% |
$2.24 +339.2% |
| Total Assets | $528.59M -16.8% |
$635.52M -87.9% |
$5.27B -13.4% |
$6.09B +3.1% |
$5.90B +14.1% |
$5.17B +58.8% |
| Cash and Equivalents | $91.07M -31.9% |
$133.67M +4.0% |
$128.55M -91.2% |
$1.47B -35.4% |
$2.27B +26.1% |
$1.80B +25.1% |
| Long-Term Debt | $75.24M -37.3% |
$120.02M -82.5% |
$684.21M -5.9% |
$726.85M +1111.4% |
$60.00M | — |
| Stockholders Equity | $251.59M -28.3% |
$350.88M -86.9% |
$2.67B -8.5% |
$2.92B +7.0% |
$2.73B +9.2% |
$2.50B +38.1% |
| R&D Expense | $46.16M -10.4% |
$51.50M -33.4% |
$77.30M -85.0% |
$515.08M -4.3% |
$538.01M +24.9% |
$430.82M +63.7% |
| Operating Income | -$47.25M -55.2% |
-$30.45M +50.8% |
-$61.86M -165.8% |
$93.94M -46.1% |
$174.20M -71.3% |
$606.48M +65.8% |
| Gross Profit | $70.23M -24.0% |
$92.36M -22.3% |
$118.86M -90.9% |
$1.31B -2.0% |
$1.33B -9.2% |
$1.47B +56.2% |
| Shares Outstanding | — | — | — | — | — | — |
- Zepp Health Corp reported Total Revenue of $182.60 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -92.7% in Total Revenue compared to the prior fiscal year.
- Zepp Health Corp reported Revenue (ASC 606) of $182.60 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -48.3% in Revenue (ASC 606) compared to the prior fiscal year.
- Zepp Health Corp reported Net Income of -$75.73 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -144.1% in Net Income compared to the prior fiscal year.
- Zepp Health Corp reported Diluted EPS of $0.29 per share (loss) for fiscal year 2024.
- Zepp Health Corp showed a decrease of -123.1% in Diluted EPS compared to the prior fiscal year.
- Zepp Health Corp reported Total Assets of $528.59 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -16.8% in Total Assets compared to the prior fiscal year.
- Zepp Health Corp reported Cash and Equivalents of $91.07 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -31.9% in Cash and Equivalents compared to the prior fiscal year.
- Zepp Health Corp reported Long-Term Debt of $75.24 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -37.3% in Long-Term Debt compared to the prior fiscal year.
- Zepp Health Corp reported Stockholders Equity of $251.59 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -28.3% in Stockholders Equity compared to the prior fiscal year.
- Zepp Health Corp reported R&D Expense of $46.16 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -10.4% in R&D Expense compared to the prior fiscal year.
- Zepp Health Corp reported Operating Income of -$47.25 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -55.2% in Operating Income compared to the prior fiscal year.
- Zepp Health Corp reported Gross Profit of $70.23 million for fiscal year 2024.
- Zepp Health Corp showed a decrease of -24.0% in Gross Profit compared to the prior fiscal year.
- Zepp Health Corp reported Shares Outstanding of 0 shares for fiscal year 2018.
- Zepp Health Corp showed a decrease of -100.0% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: